Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Róbert Wessman to continue serving as Executive Chairman in full-time capacityLisa Graver appointed Chief Executive Officer REYKJAVIK, ICELAND (January 6, 2026) — Alvotech (NASDAQ: ALVO), a global...
Read More -
- Róbert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech...
Read More
-
Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "2025 Global Marketplaces Report" report has been added to ResearchAndMarkets.com's offering. Transactions are no longer optional - they're the...
-
Chicago, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The global cell and gene therapy market was valued at US$ 36.5 billion in 2025 and is expected to reach US$ 183.1 billion by 2035, growing at a CAGR of...
-
BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012DEE: 63.3%...
-
- Róbert Wessman to continue serving as Executive Chairman in full-time capacity - Lisa Graver appointed Chief Executive Officer REYKJAVIK, Iceland, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Alvotech...
-
Róbert Wessman to continue serving as Executive Chairman in full-time capacityLisa Graver appointed Chief Executive Officer REYKJAVIK, ICELAND (January 6, 2026) — Alvotech (NASDAQ: ALVO), a global...
-
HONG KONG, Jan. 06, 2026 (GLOBE NEWSWIRE) -- It’s been a banner year for Hong Kong’s restaurant, bar and hospitality scene. Fresh off its historic achievement, in which venues in Hong Kong became...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...
-
FREDERICK, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases,...
-
ITASCA, Ill., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Riverside Insights, a leading provider of trusted, research-backed assessments, today announced a new international distribution partnership with...
-
RESEARCH TRIANGLE PARK, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted...